Petros Pharmaceuticals PTPI
OTC PTPI
$0.00 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Petros Pharmaceuticals, Inc. (PTPI) EBIT Margin (2020 - 2026)

Updated

Petros Pharmaceuticals (PTPI) posted EBIT Margin of -123.51% for Q2 2023, down 83.83 percentage points from -39.69% a year earlier and down 71.51 percentage points from the prior quarter.

Analysis

Petros Pharmaceuticals, Inc. (PTPI) EBIT Margin (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2023, EBIT Margin at Petros Pharmaceuticals was -559.27%, down 386.35 percentage points year-over-year; for FY2022, it came in at -332.37%, down 101.32 percentage points from FY2021.

  • In prior years, Petros Pharmaceuticals' EBIT Margin was -231.05% in FY2021 (-50.27 pp) and -180.78% in FY2020.
  • Quarterly EBIT Margin has run from a low of -513.86% in Q4 2022 to a high of -19.52% in Q1 2022 over five years.
  • On a year-over-year basis, EBIT Margin increased in two of the last five quarters, with an average year-over-year change of -9.53 percentage points.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,091.38%
Mar 31, 2026 -2,558.80%
Dec 31, 2025 -734.77%
Sep 30, 2025 -1,478.40%
Jun 30, 2025 -2,026.78%
Mar 31, 2025 -3,051.58%
Dec 31, 2024 -2,334.40%
Sep 30, 2024 -1,579.25%
Jun 30, 2024 -1,129.99%
Mar 31, 2024 -989.95%
Dec 31, 2023 -2,213.91%
Sep 30, 2023 -2,852.93%
Jun 30, 2023 -123.51%
Mar 31, 2023 -52.00%
Dec 31, 2022 -513.86%
Jun 30, 2022 -39.69%
Mar 31, 2022 -19.52%
Sep 30, 2021 -167.66%
Jun 30, 2021 -174.18%
Mar 31, 2021 -53.92%
API Access

Petros Pharmaceuticals, Inc. EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PTPI&period=max&api_key=YOUR_API_KEY